Year

2007

Status

Exited

 

Team

Field

Oncology diagnostic

Location

Nijmegen (The Netherlands)

Fund

BGV I

NovioGendix

NovioGendix is developing a new biomarker panel for the detection and management of prostate cancer and other cancers. In 2010 MDxHealth acquired NovioGendix.